Area of research
Ophthalmology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Corneal surgery and disorders, Retinal Diseases and Treatments, Corneal Surgery and Treatments, and Glaucoma and retinal disorders.
Brillouin Optical Spectroscopy for In Vivo and Ex Vivo Assessment of Corneal Biomechanics
Start codon disruption with CRISPR/Cas9 prevents murine Fuchs’ endothelial corneal dystrophy
Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of Macromolecules
COMP-Ang1 Stabilizes Hyperglycemic Disruption of Blood-Retinal Barrier Phenotype in Human Retinal Microvascular Endothelial Cells
Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis
Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice
Pediatric keratoconus: a review of the literature
New capsular tension segment with 2-point fixation for zonular weakness
Risk factors and biomarkers of age-related macular degeneration
TRPV4 regulates calcium homeostasis, cytoskeletal remodeling, conventional outflow and intraocular pressure in the mammalian eye
Human IgG1 antibodies suppress angiogenesis in a target-independent manner
Neurodegeneration severity can be predicted from early microglia alterations monitored<i>in vivo</i>in a mouse model of chronic glaucoma
Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic Retinopathy
<em>In Vivo </em>Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications
DICER1/ <i>Alu</i> RNA dysmetabolism induces Caspase-8–mediated cell death in age-related macular degeneration
IL-18 is not therapeutic for neovascular age-related macular degeneration
Angiographic Features of Transgenic Mice With Increased Expression of Human Serine Protease HTRA1 in Retinal Pigment Epithelium
The Reduction of Serum Soluble Flt-1 in Patients With Neovascular Age-Related Macular Degeneration
Targeted Intraceptor Nanoparticle Therapy Reduces Angiogenesis and Fibrosis in Primate and Murine Macular Degeneration
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1
Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity
Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation
DICER1 Loss and Alu RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88
ERK1/2 activation is a therapeutic target in age-related macular degeneration
Ocular Drug Delivery for Glaucoma Management
Nanoparticle-Mediated Delivery of shRNA.VEGF-A Plasmids Regresses Corneal Neovascularization
Flt23k Nanoparticles Offer Additive Benefit in Graft Survival and Anti-Angiogenic Effects When Combined with Triamcinolone
Morpholino-Mediated Increase in Soluble Flt-1 Expression Results in Decreased Ocular and Tumor Neovascularization
Dual suppression of hemangiogenesis and lymphangiogenesis by splice‐shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR)